MODERN BIO / BRAIN & COGNITION / SUPPLEMENT
Moderate evidenceOmega-3 EPA/DHA
This page is a practical starting point—not a diagnosis or personalized prescription. Use the evidence, limitations and safety context to prepare a better decision.
THE PRACTICAL PROTOCOL
How to try it without overcomplicating it.
Prioritize fatty fish when appropriate and verify third-party testing and oxidation control.RECOMMENDED RANGES
Men and women may need different context.
We only show a different amount when physiology, dietary requirements or clinical evidence supports it. Otherwise, we say the range is the same.Typical guidance
Common supplemental study range: 1–2 g/day combined EPA + DHA.
Typical guidance
Common supplemental study range: 1–2 g/day combined EPA + DHA; pregnancy changes product-quality priorities.
Important context: Diet, cardiovascular risk, bleeding risk and treatment goal determine the appropriate amount.
EVIDENCE IN CONTEXT
What the evidence really says.
This intervention is included in the brain & cognition roadmap because it may influence a relevant, trackable outcome. The evidence grade below reflects the quality and consistency of human research—not popularity, testimonials or marketing.
Promising human evidence exists, but studies, populations or results have meaningful limitations.
YOUR ACTION PLAN
Turn the idea into a useful experiment.
Define why you are considering omega-3 epa/dha, check medications and conditions, and choose a transparent, independently tested formulation.
Record product, amount, timing, start date, intended benefit, side effects and the date you will judge the trial.
Keep food, sleep and training reasonably stable so you can tell whether the supplement—not several simultaneous changes—made a difference.
Stop for a concerning reaction, a meaningful interaction, no worthwhile benefit by the review date or advice from your clinician.
QUALITY CHECK
What to look for
- The exact active ingredient and amount used in research relevant to omega-3 epa/dha; avoid judging by front-label marketing.
- Independent identity, potency and contaminant testing from a credible third party or accessible certificate of analysis.
- No undisclosed proprietary blend, exaggerated disease claim or unnecessary stack of overlapping ingredients.
- A review of medications, conditions, total intake and the specific result that would justify continuing.
SAFETY & INTERACTIONS
What to know first
Review blood thinners, bleeding disorders and high-dose use with a clinician.
SCIENTIFIC EVIDENCE
Read the data yourself.
These high-level sources establish the scientific context for brain & cognition. The live PubMed link narrows the literature to omega-3 epa/dha.Dementia prevention, intervention, and care: 2024 Lancet Commission
Synthesizes modifiable dementia risks across the life course and estimates that addressing identified risk factors could prevent or delay a substantial share of cases.
Open scientific source ↗Life's Essential 8
Defines eight measurable behaviors and health factors for cardiovascular health—an important foundation for vascular brain health.
Open scientific source ↗Search Omega-3 EPA/DHA on PubMed
See the current indexed biomedical literature, including newer trials and reviews added after this page was published.
Open live PubMed search ↗Research quality is not determined by citation count alone. We consider design, sample size, controls, consistency, relevance, conflicts and whether the outcome was clinically meaningful.
MODERN BIO SELECT
The best option—regardless of commission.
We do not sell the top placement. Every winner must earn it through evidence, quality, safety, transparency and real-world value.Best Omega-3 EPA/DHA product
We are comparing formulation, clinically relevant serving, contaminant testing, label transparency, value and manufacturer quality before naming a winner.
Get notified when selected →Best professional guidance
Our provider directory will prioritize credentialed clinicians and registered dietitians who evaluate the full picture before recommending a supplement.
Join the provider shortlist →NEXT STEP